San Diego, CA, United States of America

Farbod Shojaei

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Farbod Shojaei

Introduction

Farbod Shojaei is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of SHP2 inhibitors. With a total of 5 patents to his name, Shojaei is recognized for his impactful work in the medical and pharmaceutical industries.

Latest Patents

Among his latest patents, Shojaei has developed a method for using SHP2 inhibitors in monotherapy aimed at reducing solid tumors in cancer patients. This groundbreaking approach provides new avenues for cancer treatment. Additionally, he has created combination therapies that include SHP2 inhibitors and PD-1 inhibitors, which offer promising methods for treating various forms of cancer.

Career Highlights

Throughout his career, Farbod Shojaei has worked with notable companies such as Bionomics Inc. and Huyabio International, LLC. His experience in these organizations has allowed him to collaborate with leading experts in the field and further his research endeavors.

Collaborations

Some of his coworkers include Christopher L. Reyes and Peter Chu, who have contributed to his projects and research initiatives. Their collaboration has been instrumental in advancing the development of innovative cancer therapies.

Conclusion

Farbod Shojaei's work exemplifies the spirit of innovation in the medical field. His patents and research are paving the way for new cancer treatments that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…